Drug profile · INN
trastuzumab duocarmazine
JIVADCO
trastuzumab duocarmazine (JIVADCO) is a receptor protein-tyrosine kinase erbb-2 binding agent.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trastuzumab duocarmazine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
trastuzumab duocarmazine (JIVADCO) is a receptor protein-tyrosine kinase erbb-2 binding agent.
Key facts
INN trastuzumab duocarmazine
Brand JIVADCO
Mechanism Receptor protein-tyrosine kinase erbB-2 binding agent
Target DNA
Mechanism of action
Receptor protein-tyrosine kinase erbB-2 binding agent
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is trastuzumab duocarmazine?
trastuzumab duocarmazine (JIVADCO) is a receptor protein-tyrosine kinase erbb-2 binding agent.
What is the brand name for trastuzumab duocarmazine?
JIVADCO is a marketed brand name for trastuzumab duocarmazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.